Bill summaries are authored by CRS.

Shown Here:
Passed House amended (05/19/1998)

TABLE OF CONTENTS:

Title I: Hemophilia Relief Fund

Title II: Treatment of Certain Payments in

Hemophilia-Clotting-Factor Suit under the Medicaid and

SSI Programs

Ricky Ray Hemophilia Relief Fund Act of 1998 - Title I: Hemophilia Relief Fund - Establishes in the Treasury the Ricky Ray Hemophilia Relief Fund. Terminates the Fund five years after enactment of this Act. Authorizes appropriations.

(Sec. 102) Mandates a single payment of $100,000 from the Fund to any individual infected with the human immunodeficiency virus (HIV) if the individual has any blood-clotting disorder and was treated with blood-clotting agents between July 1, 1982, and December 31, 1987, is the lawful current or former spouse of such an individual, or acquired the HIV infection from a parent who is such an individual.

(Sec. 103) Declares that: (1) this Act does not create or admit any claim of the individual against the United States or its agents regarding HIV and antihemophilic factor treatment; and (2) acceptance of a payment under this Act is in full satisfaction of all such claims of the individual.

(Sec. 105) Prohibits any payment under this Act unless the petition is filed within three years after enactment of this Act.

(Sec. 107) Limits, notwithstanding any contract, the amount an individual's representative may receive for services in connection with a petition.

Title II: Treatment of Certain Payments in Hemophilia-Clotting-Factor Suit under the Medicaid and SSI Programs - Prohibits a settlement payment under certain class action lawsuits from being considered income or resources in determining eligibility for, or the amount of, medical assistance under the Medicaid program or benefits under the Supplemental Security Income (SSI) program (titles XIX and XVI of the Social Security Act). Prohibits Government payments under title I of this Act from being considered income or resources in determining eligibility for, or the amount of, SSI benefits.